Navigation Links
'NMR on a chip' features NIST magnetic mini-sensor
Date:2/19/2008

A super-sensitive mini-sensor developed at the National Institute of Standards and Technology (NIST) can detect nuclear magnetic resonance (NMR) in tiny samples of fluids flowing through a novel microchip. The prototype chip device, developed in a collaboration between NIST and the University of California, may have wide application as a sensitive chemical analyzer, for example in rapid screening to find new drugs.

As described in Proceedings of the National Academy of Sciences (PNAS),* the NMR chip detected magnetic signals from atomic nuclei in tap water flowing through a custom silicon chip that juxtaposes a tiny fluid channel and the NIST sensor. The Berkeley group recently co-developed this remote NMR technique for tracking small volumes of fluid or gas flow inside soft materials such as biological tissue or porous rock, for possible applications in industrial processes and oil exploration. The chip could be used in NMR spectroscopy, a widely used technique for determining physical, chemical, electronic and structural information about molecules. NMR signals are equivalent to those detected in MRI (magnetic resonance imaging) systems

Berkeley scientists selected the NIST sensor, a type of atomic magnetometer, for the chip device because of its small size and high sensitivity, which make it possible to detect weak magnetic resonance signals from a small sample of atoms in the adjacent microchannel. Detection is most efficient when the sensor and sample are about the same size and located close together, lead author Micah Ledbetter says. Thus, when samples are minute, as in economical screening of many chemicals, a small sensor is crucial, Ledbetter says.

Its small size and extreme sensitivity make the NIST sensor ideal for the microchip device, in contrast to SQUIDs (superconducting quantum interference devices) that require bulky equipment for cooling to cryogenic temperatures or conventional copper coils that need much hig
'/>"/>

Contact: Laura Ost
laura.ost@nist.gov
303-497-4880
National Institute of Standards and Technology (NIST)
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
2. Pelosi: SCHIP Bill a Giant Step for Americas Children
3. Childrens Hospitals in Washington to Lobby Congress to Reauthorize SCHIP Now
4. Governor Rendell Announces CHIP Enrollment Clinics at Several Rite Aid Stores
5. Center for Health Transformation Founder Newt Gingrich Calls on Congress to Pass a Clean SCHIP Six-Month Extension
6. Gene chip data improved therapy in some patients with incurable cancer
7. Deep concern and disappointment with exclusion of Medicare from SCHIP legislation
8. Gene Chip Data Can Boost Cancer Outcomes
9. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
10. APHA Urges President Bush to Reconsider Unfounded Basis for SCHIP Veto
11. Statement on House/Senate Agreement on SCHIP Legislation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'NMR on a chip' features NIST magnetic mini-sensor
'NMR on a chip' features NIST magnetic mini-sensor
Other Medicine News:Health News:Helping to Clear the Air for Consumers - New Certification Standard for HEPA Filters Will Help Millions of People Make More Educated Choices 2Health News:SAFC Supply Solutions Introduces Certified Organics to Flavors & Fragrances Product Line 2Health News:SAFC Supply Solutions Introduces Certified Organics to Flavors & Fragrances Product Line 3Health News:SAFC Supply Solutions Introduces Certified Organics to Flavors & Fragrances Product Line 4Health News:Official Launch of ABLE TO CHOOSE Public Awareness Campaign 2Health News:Breast Cancer Action Victorious in Yoplait 'Pinkwashing' Campaign 2Health News:During National Wise Health Consumer Month: Consumers Seek Cost-Effective Health Care 2Health News:During National Wise Health Consumer Month: Consumers Seek Cost-Effective Health Care 3Health News:During National Wise Health Consumer Month: Consumers Seek Cost-Effective Health Care 4Health News:During National Wise Health Consumer Month: Consumers Seek Cost-Effective Health Care 5Health News:Autism Consortium members publish in PNAS: Mechanism, treatment for Rett syndrome -- top cause autism girls 2Health News:Autism Consortium members publish in PNAS: Mechanism, treatment for Rett syndrome -- top cause autism girls 3
Breaking Medicine Technology:FDA Launches Orphan Drug Workshop at KGI 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3MoviMED Announces Participation in NIWeek 2009 Conference to Examine Trends and Technologies for Boosting Productivity and Increasing Competitive Adva 52876 1MoviMED Announces Participation in NIWeek 2009 Conference to Examine Trends and Technologies for Boosting Productivity and Increasing Competitive Adva 52876 2MoviMED Announces Participation in NIWeek 2009 Conference to Examine Trends and Technologies for Boosting Productivity and Increasing Competitive Adva 52876 3Huntsville Alabama Plastic Surgeon David L Durst MD Comments on Silicone Breast Implants after Nearly 3 Years on the Open Market 52871 1Huntsville Alabama Plastic Surgeon David L Durst MD Comments on Silicone Breast Implants after Nearly 3 Years on the Open Market 52871 2Huntsville Alabama Plastic Surgeon David L Durst MD Comments on Silicone Breast Implants after Nearly 3 Years on the Open Market 52871 3FDA Issues Complete Response Letter for INTUNIV 28TM 29 28guanfacine 29 Extended Release for the Treatment of ADHD in Children and Adolescents 4786 1FDA Issues Complete Response Letter for INTUNIV 28TM 29 28guanfacine 29 Extended Release for the Treatment of ADHD in Children and Adolescents 4786 2FDA Issues Complete Response Letter for INTUNIV 28TM 29 28guanfacine 29 Extended Release for the Treatment of ADHD in Children and Adolescents 4786 3FDA Issues Complete Response Letter for INTUNIV 28TM 29 28guanfacine 29 Extended Release for the Treatment of ADHD in Children and Adolescents 4786 4FDA Issues Complete Response Letter for INTUNIV 28TM 29 28guanfacine 29 Extended Release for the Treatment of ADHD in Children and Adolescents 4786 5FDA Issues Complete Response Letter for INTUNIV 28TM 29 28guanfacine 29 Extended Release for the Treatment of ADHD in Children and Adolescents 4786 6